Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AGQW | ISIN: US81727U1051 | Ticker-Symbol: 6L6
Tradegate
06.06.25 | 16:50
0,460 Euro
-0,69 % -0,003
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SENSEONICS HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
SENSEONICS HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,4510,47506.06.
0,4540,47406.06.

Aktuelle News zur SENSEONICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSenseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense 365 Continuous Glucose Monitoring System for People with Diabetes4
MoH.C. Wainwright stuft Senseonics-Aktie mit Kaufempfehlung und Kursziel von 1,10 US-Dollar ein7
21.05.Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement4
16.05.Senseonics Holdings, Inc. - 8-K, Current Report2
SENSEONICS Aktie jetzt für 0€ handeln
16.05.Senseonics announces pricing of $50 million public offering2
16.05.Senseonics Holdings, Inc.: Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement5
15.05.Senseonics opens $50M public offering, $25M private placement with Abbott6
15.05.Senseonics Holdings announces underwritten public offering3
15.05.Senseonics Holdings, Inc.: Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement1
09.05.Senseonics targets $34M-$38M revenue in 2025 with Eversense 365 expansion13
08.05.Senseonics Holdings, Inc. - 10-Q, Quarterly Report2
07.05.Senseonics Q1 2025 Earnings Preview4
07.05.Senseonics Holdings' Earnings: A Preview4
29.04.Sequel Med Tech, Senseonics to integrate year-long CGM into automated insulin delivery system3
29.04.Senseonics Holdings, Inc.: Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)6
09.04.Mizuho sets Senseonics stock Outperform with $2 target5
05.03.H.C. Wainwright maintains Buy rating on Senseonics stock at $2 target7
03.03.Senseonics beats on Q4 earnings; bullish 2025 revenue outlook15
03.03.Senseonics Holdings, Inc. Full Year Loss Increases, But Beats Estimates5
03.03.Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results250Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately...
► Artikel lesen
Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1